From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options

Jan van Meerbeeck (Edegem (Antwerp), Belgium)

Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jan van Meerbeeck (Edegem (Antwerp), Belgium). From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options. International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A new definition of multimodality treatment
Source: International Congress 2016 – Oligometastasis: postmodern multimodality concepts
Year: 2016


Staging techniques needed for implementing the new staging recommendations 
Source: International Congress 2016 – PG7 New guidelines for the classification and staging of lung cancer
Year: 2016


Modern staging in lung cancer: from the current multidisciplinary process to novel approaches
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


Individualised staging: practical implications
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Approaches to radiological staging of mesothelioma relating to modern treatment modalities
Source: Virtual Congress 2021 – Thoracic oncology
Year: 2021


Imaging and staging: impact of new techniques
Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer
Year: 2006

New treatment concepts in stage IV NSCLC: personalized multidisciplinary approaches
Source: Virtual Congress 2021 – Hot topics in thoracic oncology
Year: 2021


COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness
Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020
Year: 2020



Contemporary diagnostics and staging
Source: Annual Congress 2012 - PG10 An update on mesothelioma diagnostics and treatment
Year: 2012

Regional chemotherapy: a new combined modality approach
Source: Annual Congress 2004 - Lung metastases
Year: 2004

PET-CT a useful staging tool for patients with non small lung cancer when applied based on surgeons‘ discretion as well as guidelines
Source: Annual Congress 2010 - State of the art imaging
Year: 2010

Multimodal therapy in mesothelioma: which modalities are available and useful and how to combine them
Source: International Congress 2014 – Mesothelioma: a never-ending story
Year: 2014



Fitness for radical treatment modalities: efficient functional assessment, improving fitness and fitness-adapted therapy concepts including the elderly
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017


Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018